In 2019 SRX Health Solutions entered the clinical trials space by securing a majority ownership of TDDA Specialty Research headquartered in Toronto, ON. TDDA Specialty Research functions within the SRx Clinical Trials division.

TDDA is an established leader in clinical trial research, working with the industry and healthcare community to advance therapeutic treatment options.

With this expansion, SRX Health Solutions is now able to bring manufacturers, physicians and their patients one step closer to accessing approved clinical trials.